Employees Retirement System of Texas’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,885
Closed -$2.81M 333
2023
Q4
$2.81M Hold
20,885
0.03% 217
2023
Q3
$2.83M Sell
20,885
-38,923
-65% -$5.32M 0.04% 193
2023
Q2
$8.56M Sell
59,808
-6,255
-9% -$920K 0.12% 120
2023
Q1
$9.17M Sell
66,063
-4,258
-6% -$573K 0.13% 128
2022
Q4
$9.54M Sell
70,321
-8,934
-11% -$1.12M 0.14% 168
2022
Q3
$8.69M Sell
79,255
-6,785
-8% -$861K 0.13% 180
2022
Q2
$11.4M Buy
86,040
+20,045
+30% +$2.63M 0.16% 165
2022
Q1
$8.76M Buy
65,995
+19,455
+42% +$2.33M 0.1% 228
2021
Q4
$5.42M Sell
46,540
-64,626
-58% -$7.6M 0.06% 318
2021
Q3
$13.4M Buy
+111,166
New +$12.9M 0.16% 169

Other funds holding AZN

Employees Retirement System of Texas's AZN Position: Q1 2024 in Review

Employees Retirement System of Texas sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 20,885 shares — an estimated $2.81M sold.

Employees Retirement System of Texas first reported a position in AZN in Q3 2021 and held it in 10 quarters. The position peaked at $13.4M in Q3 2021. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

  • Employees Retirement System of Texas reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
  • Employees Retirement System of Texas sold 20,885 AstraZeneca shares in Q1 2024, an estimated $2.81M.
  • Employees Retirement System of Texas first reported a position in AstraZeneca in Q3 2021 and held it in 10 quarters.
  • Employees Retirement System of Texas's AstraZeneca position peaked at $13.4M in Q3 2021.
  • 1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Employees Retirement System of Texas's 13F filing for Q1 2024, filed 15 May 2024.